.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Julia Stingl

Aachen / DE

University Hospital RWTH Aachen

Vorsitz

27.03.2025
10:15 – 11:45
Symposien
Detecting pharmacogenetic genotype-phenotype discrepancies in patient populations
Hörsaal B
28.03.2025
13:30 – 15:00
Symposien
Clinical pharmacology in academic driven advanced therapy and drug development – chances and opportunities
Hörsaal C

Speaker

26.03.2025
14:14 – 14:36 18 Min. 4 Min.
Lecture
Drug-drug-gene interaction: What to consider during polypharmacy

Vortrag

27.03.2025
Poster Self-Study
P214
Establishment of a Pharmacogenomic working group in the 1+Million Genome Project
Applied Pharmacology, Pharmacogenomics and personalized medicine

Weitere Beteiligungen

26.03.2025
Poster Self-Study
P033
Pharmacogenetic impact of CYP2B6 variants on steroid hormone metabolism in breast cancer cells
Applied Pharmacology, Cancer pharmacology
26.03.2025
Poster Self-Study
P101
Green Tea catechins act as substrates and mediate inhibition of organic anion transporting polypeptide 1A2 and its most common genetic variant in vitro
Basic Research, Drug transport/delivery and metabolism
26.03.2025
Poster Self-Study
P103
Solanidine is a potent inhibitor of CYP2D6 in vitro
Basic Research, Drug transport/delivery and metabolism
27.03.2025
Poster Self-Study
P212
Functional Impact of CYP2B6 and CYP2C8 Variants: Mechanisms of Uncoupling and Implications for Extra-Hepatic Toxicity
Applied Pharmacology, Pharmacogenomics and personalized medicine
27.03.2025
Poster Self-Study
P214
Establishment of a Pharmacogenomic working group in the 1+Million Genome Project
Applied Pharmacology, Pharmacogenomics and personalized medicine